Borderline Ovarian Tumors
暂无分享,去创建一个
[1] M. E. Kirk,et al. Surgery as sole treatment for serous borderline tumors of the ovary with noninvasive implants. , 2003, Gynecologic oncology.
[2] J. Squifflet,et al. Safety of conservative management and fertility outcome in women with borderline tumors of the ovary. , 2003, Fertility and sterility.
[3] D. Querleu,et al. Laparoscopic restaging of borderline ovarian tumours: results of 30 cases initially presumed as stage IA borderline ovarian tumours , 2003, BJOG : an international journal of obstetrics and gynaecology.
[4] R. Kurman,et al. Diagnostic Criteria and Behavior of Ovarian Seromucinous (Endocervical-Type Mucinous and Mixed Cell-Type) Tumors: Atypical Proliferative (Borderline) Tumors, Intraepithelial, Microinvasive, and Invasive Carcinomas , 2002, The American journal of surgical pathology.
[5] C. Olsen,et al. Surgical Staging in Patients With Ovarian Tumors of Low Malignant Potential , 2002, Obstetrics and gynecology.
[6] F. Montz,et al. Recurrent micropapillary serous ovarian carcinoma , 2002, Cancer.
[7] D. Atallah,et al. Fertility results after conservative treatment of advanced stage serous borderline tumour of the ovary , 2002, BJOG : an international journal of obstetrics and gynaecology.
[8] D. Bodurka,et al. Response and Survival in Patients With Progressive or Recurrent Serous Ovarian Tumors of Low Malignant Potential , 2002, Obstetrics and gynecology.
[9] A. Berchuck,et al. Types and duration of symptoms prior to diagnosis of invasive or borderline ovarian tumor. , 2001, Gynecologic oncology.
[10] P. Dickman,et al. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study. , 2001, Gynecologic oncology.
[11] J. Gu,et al. Molecular evidence for the independent origin of extra-ovarian papillary serous tumors of low malignant potential. , 2001, Journal of the National Cancer Institute.
[12] C. Mangioni,et al. Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] A. Lissoni,et al. Ultrasound, physical examination, and CA 125 measurement for the detection of recurrence after conservative surgery for early borderline ovarian tumors. , 2001, Gynecologic oncology.
[14] R. Kurman,et al. Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors: atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas. , 1999, The American journal of surgical pathology.
[15] R. Scully,et al. Ovarian serous borderline tumors with micropapillary and cribriform patterns: a study of 40 cases and comparison with 44 cases without these patterns. , 1999, The American journal of surgical pathology.
[16] D. Gershenson,et al. The current status of surgical staging of ovarian serous borderline tumors , 1999, Cancer.
[17] D. Gershenson,et al. Serous borderline tumors of the ovary with noninvasive peritoneal implants , 1998, Cancer.
[18] B. Modan,et al. Rates of Jewish ancestral mutations in BRCA1 and BRCA2 in borderline ovarian tumors. , 1998, Journal of the National Cancer Institute.
[19] L. Levy,et al. Ovarian serous borderline tumors with invasive peritoneal implants , 1998, Cancer.
[20] C. la Vecchia,et al. Treatment for fertility and risk of ovarian tumors of borderline malignancy. , 1998, Gynecologic oncology.
[21] R. Kurman,et al. Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases. , 1996, The American journal of surgical pathology.
[22] M. Sherman,et al. Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. , 1996, The American journal of surgical pathology.
[23] R. Barakat,et al. Laparotomy to Complete Staging of Presumed Early Ovarian Cancer , 1996, Obstetrics and gynecology.
[24] E. Yordan,et al. Preliminary analysis of the behavior of stage I ovarian serous tumors of low malignant potential: a Gynecologic Oncology Group study. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] K. Jablonski,et al. Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential. , 1995, Human pathology.
[26] V. Abeler,et al. Are borderline tumors of the ovary overtreated both surgically and systemically? A review of four prospective randomized trials including 253 patients with borderline tumors. , 1993, Gynecologic oncology.
[27] R. Kurman,et al. The behavior of serous tumors of low malignant potential: are they ever malignant? , 1993, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[28] J. Woodruff,et al. Long-term follow-up of serous ovarian tumors of low malignant potential. , 1992, Gynecologic oncology.
[29] R. Knapp,et al. Unifocal origin of advanced human epithelial ovarian cancers. , 1992, Cancer research.
[30] J. Leake. Tumors of low malignant potential , 1992, Current opinion in obstetrics & gynecology.
[31] R. Scully,et al. Ovarian serous borderline tumors with stromal microinvasion : a report of 21 cases , 1990 .
[32] Scully Re,et al. Ovarian cystectomy for serous borderline tumors: a follow-up study of 35 cases. , 1988 .
[33] N. Weiss,et al. Case-control study of borderline ovarian tumors: reproductive history and exposure to exogenous female hormones. , 1988, Cancer research.
[34] W. R. Hart,et al. Intestinal adenocarcinomas metastatic to the ovaries. A clinicopathologic evaluation of 22 cases. , 1987, The American journal of surgical pathology.
[35] Aimo Ojala. Studies on Bilirubin in Amniotic Fluid: With Special Reference to Liver Function Tests , 1971, Acta obstetricia et gynecologica Scandinavica. Supplement.